Filter
Showing 25–29 of 29 results
-
Tesamorelin, an analogue of growth hormone releasing
hormone (GHRH), mirrors the structure of standard GHRH,
enhanced by the addition of an extra trans-3-hexanoic acid
group. Developed by Theratechnologies in Canada,
Tesamorelin earned FDA approval in 2010 as the latest
drug for managing HIV-associated lipodystrophy. Beyond
its approved use, the peptide has undergone exploration
regarding its potential to enhance peripheral nerve
regeneration and as a potential intervention for mild
cognitive impairment (MCI), which precedes dementia.
$80.00
-
Thymosin alpha-1, a naturally occurring peptide segment,
was initially identified back in 1972. Subsequently, it has
undergone extensive examination in clinical trials across
various medical conditions including cystic fibrosis,
infections like tuberculosis and cytomegalovirus,
respiratory disorders, chronic hepatitis, and cancer.
Notably, it has secured approval for combatting chronic
hepatitis B and C infections in 35 under-developed nations
$80.00
-
Thymalin, a synthetic iteration of thymulin discovered in
1977 within the thymus, has exhibited multiple roles,
including regulation of inflammation and pain, fostering
neuroprotective effects, and playing a significant part in
immune functionality. Initial investigations also indicated
that thymalin, along with extracts from the thymus and
pineal gland, might contribute to prolonging life.
$100.00
-
-